Bookmark and Share
BioAssay: AID 651889

Inhibition of Plasmodium falcipirum NF54 Measured in Cell-Based System Using Plate Reader - 2138-11_Inhibitor_Dose_DryPowder_Activity

Expected Outcome: Compounds significantly suppressing Alamar blue, and P. falciparum proliferation, are considered active. ..more
_
   
 Tested Compounds
 Tested Compounds
All(8)
 
 
Inactive(8)
 
 
 Tested Substances
 Tested Substances
All(8)
 
 
Inactive(8)
 
 
 Related BioAssays
 Related BioAssays
AID: 651889
Data Source: Broad Institute (2138-11_Inhibitor_Dose_DryPowder_Activity)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Screening Center Network, Assay Provider
BioAssay Version:
Deposit Date: 2012-12-07
Hold-until Date: 2013-07-15
Modify Date: 2013-07-16

Data Table ( Complete ):           All
Tested Compounds:
Depositor Specified Assays
AIDNameTypeComment
624280Broad Institute Inhibition of T.cruzi replication in culture Inhibitor Probe Projectsummarysummary
Description:
Keywords: Plasmodium, malaria, Plasmodium falciparum


Assay Overview:
In vitro activity against erythrocytic stages of P. falciparum.

Expected Outcome: Compounds significantly suppressing Alamar blue, and P. falciparum proliferation, are considered active.
Protocol
In vitro activity against erythrocytic stages of P. falciparum was determined using a 3H-hypoxanthine incorporation assay (Desjardins et al. 1979, Matiel and Pink. 1990), using the drug sensitive NF54 strain (Schipol Airport, The Netherlands, Ponnudurai et al. 1981) and the standard drug chloroquine (Sigma C6628). Compounds were dissolved in DMSO at 10 mg/ml and added to parasite cultures incubated in RPMI 1640 medium without hypoxanthine, supplemented with HEPES (5.94 g/l), NaHCO3 (2.1 g/l), neomycin (100 U/ml), AlbumaxR (5 g/l) and washed human red cells A+ at 2.5% haematocrit (0.3% parasitaemia). Serial drug dilutions of eleven 3-fold dilution steps covering a range from 100 to 0.002 ig/ml were prepared. The 96-well plates were incubated in a humidified atmosphere at 37 degrees C; 4% CO2, 3% O2, 93% N2. After 48 h 50 il of 3H-hypoxanthine (=0.5 iCi) was added to each well of the plate. The plates were incubated for a further 24 h under the same conditions. The plates were then harvested with a Betaplatetrade mark cell harvester (Wallac, Zurich, Switzerland), and the red blood cells transferred onto a glass fibre filter then washed with distilled water. The dried filters were inserted into a plastic foil with 10 ml of scintillation fluid, and counted in a Betaplatetrade mark liquid scintillation counter (Wallac, Zurich, Switzerland). IC50 values were calculated from sigmoidal inhibition curves by linear regression (Huber 1993) using Microsoft Excel. Chloroquine and artemisinin are used as control.
Comment
Compounds with IC50 less than 25 fold the control compound, Chloroquine, were labeled active.
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1IC50_uM*FloatμM

* Activity Concentration.
Additional Information
Grant Number: 1 R03 MH085673-01

Data Table (Concise)
PageFrom: